Clinical Trial Update: Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two formulations of stavudine in HIV-infected patients to assess effectiveness and safety; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Stavudine (Zerit) (stavudine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | Phase 3 | Status: COMPLETED